
Here’s why YOU should join us at DeviceTalks Minnesota on May 4
May 1, 2026 - 00:33:16
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott i...
Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients? is an episode from DeviceTalks by DeviceTalks. In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown s...
This episode belongs to DeviceTalks.
Use the player on this page to stream the episode online.
Published Mar 31, 2026, 00:44:53 long, audio available.
In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders. Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression. The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands. Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies. This episode is brought to you by Confluent Medical Technologies . To learn more about Confluent, visit: . Make sure to catch Confluent's March DeviceTalks Tuesdays webinar highlighting its new technology, Filmcast Select™: *** Enjoy this podcast? Follow AbbottTalks on all major podcast players:
You can listen to Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients? online on Radio and Podcast. Open the player on this page to stream the available audio.
Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients? is an episode from DeviceTalks by DeviceTalks.
This episode is 00:44:53 long.
This episode was published on Mar 31, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from DeviceTalks when more episodes are available from the podcast feed.
You can listen to Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients? on this page when the episode audio is available from the podcast feed.
Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients? is from DeviceTalks by DeviceTalks.
Published Mar 31, 2026 and 00:44:53 long